Advertisement Lifeline new software wins US patent - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Lifeline new software wins US patent

Lifeline Biotechnologies has received US Patent for its software, System For Analyzing Thermal Data Based on Breast Surface Temperature to Determine Suspect Conditions.

Lifeline CEO Jim Holmes said the System patent completes Lifeline’s three software patents.

”We now have our Methods, Device and System patents which provide the Company with protection of its developed technology,” Holmes added.

”Methods for Collecting and Analyzing Thermal Data Based on Breast Surface Temperature to Determine Suspect Conditions;   Device For Analyzing Thermal Data Based On Breast Surface Temperature For Detection For Use In Determining Cancerous Conditions; and, System For Analyzing Thermal Data Based On Breast Surface Temperature To Determine Suspect Conditions.”

Lifeline Biotechnologies exclusive licensee, First Warning Systems is at present updating the patient data collection device and its interpretive software to complete the product and market it.